Uploaded and shared in Youtube by: USFoodandDrugAdmin FDA is notifying healthcare professionals about cases of a rare but serious complication, non-cirrhotic portal hypertension, in patients taking Videx (didanosine) or Videx EC, to treat HIV infection. Clinicians should monitor patients on Videx for portal hypertension and esophageal varices. They should also be aware that Videx has been associated with other hepatic effects, including lactic acidosis, hepatomegaly with steatosis, and liver failure. FDA believes that for certain patients, the clinical benefits of Videx continue to outweigh its risks, and that the decision to use the drug must be made on an individual basis. FDA Patient Safety News: April 2010 For more information, please see our website: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript.cfm?show=97#8
WHAT IS SYMPOSIER?
Symposier.com is the technological platform that will allow you (and your colleagues) to share medical information, event calendars, clinical cases, new procedures and much more with medicine professionals around the world.
Get in touch with medical professionals around the world and seize the collective experiences and knowledge to the benefit of your own patients.
Establish common-interest groups to build a collaboration network
Learn, comment and publish about local or international medical events
Seize and publish to our video, image and medical documents library
Symposier uploaded this video.
Serious Liver Disorder with Videx
Date: 19 May 2010
Uploader: Symposier
Lenght: 0m 49s
Specialty:
Cardiology
Cardiovascular Surgery
Pharmacology
